Sub-study of SPYRAL AFFIRM: Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT)

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural approach used in the SPYRAL HTN-ON MED and SPYRAL PIVOTAL - SPYRAL HTN-OFF MED clinical studies in an uncontrolled hypertensive population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Individual is diagnosed with hypertension and has a baseline office systolic blood pressure ≥140 mmHg

• Individual has a baseline office diastolic blood pressure ≥ 90 mmHg

• Individual has an average systolic baseline home blood pressure ≥135 mmHg (with ≥7 days of valid pre-procedure measurements)

• Individual has a valid 24-hour Ambulatory Blood Pressure Measurement at baseline

Locations
Other Locations
Belgium
Ziekenhuis Oost Limburg - Campus Sint-Jan
RECRUITING
Genk
CHC MontLégia
RECRUITING
Liège
Germany
Universitat des Saarlandes
RECRUITING
Homburg
Ireland
Mater Misericordiae University Hospital
RECRUITING
Dublin
Contact Information
Primary
Kari Hendlin, BS, BEng
kari.a.hendlin@medtronic.com
6123104529
Backup
Carly Loudoun, BN, MSc
rs.spyralaffirm@medtronic.com
+31 43 356 6566
Time Frame
Start Date: 2025-08-27
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 130
Treatments
Experimental: SWYFT cohort
Renal angiography and Renal Denervation (Symplicity Spyral™ multi-electrode renal denervation system)
Related Therapeutic Areas
Sponsors
Leads: Medtronic Vascular

This content was sourced from clinicaltrials.gov